The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
10,876
Sort by:
Infantile Spasm Market - 2024-2031
US$ 3,400.00
The Infantile Spasm Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparall...
June 2024
41 pages
Autoimmune Hemolytic Anemia Therapeutics Market - 2024-2031
US$ 3,400.00
The Autoimmune Hemolytic Anemia Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic fore...
June 2024
66 pages
Hypercalcemia Treatment Market - 2024-2031
US$ 3,400.00
The Hypercalcemia Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...
June 2024
49 pages
Swimming Pool Water Treatment Equipment Market - 2024-2031
US$ 3,400.00
The Swimming Pool Water Treatment Equipment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic fores...
June 2024
65 pages
Antivenom Market - 2024-2031
US$ 3,400.00
Antivenom Marketis is growing with a CAGR of 6.50% during the forecast period 2026-2035. The Antivenom Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned rese...
June 2024
35 pages
Cannabis Vaporizer Market - 2024-2031
US$ 3,400.00
The Cannabis Vaporizer Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unpar...
June 2024
44 pages
Thalassemia Treatment Market - 2024-2031
US$ 3,400.00
Thalassemia Treatment Marketis is growing with a CAGR of 10.50% during the forecast period 2026-2035. The Thalassemia Treatment Market emerges as a key focus in DataM Intelligence latest in-depth anal...
June 2024
47 pages
Xerostomia Therapeutics Market - 2024-2031
US$ 3,400.00
Xerostomia Therapeutics Marketis is growing with a CAGR of 3.80% during the forecast period 2026-2035. The Xerostomia Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth a...
June 2024
49 pages
Medicinal Cannabis Compounding Market - 2024-2031
US$ 3,400.00
Medicinal Cannabis Compounding Marketis is growing with a CAGR of 20.50% during the forecast period 2026-2035. The Medicinal Cannabis Compounding Market emerges as a key focus in DataM Intelligence la...
June 2024
56 pages
Anal Fissure Therapeutics Market - 2024-2031
US$ 3,400.00
The Anal Fissure Therapeutics Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to delive...
May 2024
51 pages
Ear Infection Treatment Market - 2024-2031
US$ 3,400.00
Ear Infection Treatment Market reached USD 16.3 billion in 2031 and, growing with a CAGR of 4.80% during the forecast period 2031-2035. The Ear Infection Treatment Market emerges as a key focus in Dat...
May 2024
49 pages
Proton Pump Inhibitors Market - 2024-2031
US$ 3,400.00
Proton Pump Inhibitors Market reached US$ 4.0 million in 2031 and, growing with a CAGR of 4.90% during the forecast period 2031-2035. The Proton Pump Inhibitors Market emerges as a key focus in DataM...
May 2024
48 pages
Ranitidine Market - 2024-2031
US$ 3,400.00
The Ranitidine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...
May 2024
36 pages
Scopolamine Market - 2024-2031
US$ 3,400.00
The Scopolamine Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled...
May 2024
37 pages
Anti-viral Therapeutics Market - 2024-2031
US$ 3,400.00
Anti-viral Therapeutics Market reached US$ 70.83 billion in 2031 and, growing with a CAGR of 4.60% during the forecast period 2031-2035. The Anti-viral Therapeutics Market emerges as a key focus in Da...
May 2024
49 pages
Zoonotic Disease Treatment Market - 2024-2031
US$ 3,400.00
The Zoonotic Disease Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliv...
May 2024
52 pages
Antiviral Drugs Market - 2024-2031
US$ 3,400.00
The Antiviral Drugs Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparall...
May 2024
41 pages
Conjunctivitis Treatment Market - 2024-2031
US$ 3,400.00
Conjunctivitis Treatment Marketis is growing with a CAGR of 3.88% during the forecast period 2026-2035. The Conjunctivitis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth...
May 2024
50 pages
Ion Channel Modulators Market - 2024-2031
US$ 3,400.00
The Ion Channel Modulators Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver u...
May 2024
48 pages
Global Weight Loss Drugs Market: Analysis By Product Type (Powders and Pills, Liquids, and Injection), By Drug Type (Prescription Drugs and Over The Counter (OTC) Drugs), By Distribution Channel (Online and Offline), By End User (Under 18 Years, 18-40 Years, 40-50 Years and Above 50 Years), By Region, Size and Trends with Impact of COVID-19 and Forecast up to 2029
US$ 2,250.00
In an era marked by surging obesity rates and prevalent lifestyle-related illnesses, the quest for effective weight loss remedies has become increasingly urgent. Despite concerted efforts in diet and...
April 2024
152 pages
Anti-Venom Market Report by Species (Snake, Scorpion, Spider, and Others), Anti-venom Type (Polyvalent Anti-venom, Monovalent Anti-venom), Mode of Action (Cytotoxic, Neurotoxic, Haemotoxic, Cardiotoxic, Myotoxic, and Others), End User (Hospitals, Clinics, Ambulatory Surgical Centers), and Region 2024-2032
US$ 2,999.00
The global anti-venom market size reached US$ 1,169.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,003.5 Million by 2032, exhibiting a growth rate (CAGR) of 6% durin...
April 2024
135 pages
Oral Proteins and Peptides Market by Drug Type (Linaclotide, Plecanatide, Calcitonin, Insulin, Octreotide), Application (Gastric and Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders), and Region 2024-2032
US$ 2,999.00
The global oral proteins and peptides market size reached US$ 1.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.3 Billion by 2032, exhibiting a growth rate (CAGR) of...
April 2024
136 pages
Diamond–Blackfan Anemia (DBA) Treatment Market - 2024-2031
US$ 3,400.00
The Diamond–Blackfan Anemia (DBA) Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic fores...
April 2024
65 pages
Hepatorenal Syndrome Market - 2024-2031
US$ 3,400.00
The Hepatorenal Syndrome Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unp...
April 2024
46 pages
Hypoxia Treatment Market - 2024-2031
US$ 3,400.00
Hypoxia Treatment Market reached US$ 77.6 million in 2022 and is expected to reach US$ 134.3 million by 2031, growing with a CAGR of 7.20% during the forecast period 2026-2031. The Hypoxia Treatment M...
March 2024
43 pages
Cholecystitis Treatment Market - 2024-2031
US$ 3,400.00
The Cholecystitis Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...
March 2024
49 pages
Acute Intermittent Porphyria Market - 2024-2031
US$ 3,400.00
Acute Intermittent Porphyria Marketis is growing with a CAGR of 5.80% during the forecast period 2026-2035. The Acute Intermittent Porphyria Market emerges as a key focus in DataM Intelligence latest...
March 2024
54 pages
Androgens and Anabolic Steroids Market - 2024-2031
US$ 3,400.00
The Androgens and Anabolic Steroids Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to...
March 2024
57 pages
Gallbladder Treatment Market - 2024-2031
US$ 3,400.00
Gallbladder Treatment Marketis is growing with a CAGR of 6.20% during the forecast period 2026-2035. The Gallbladder Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analy...
March 2024
47 pages
Neurocutaneous Syndrome Market - 2024-2031
US$ 3,400.00
The Neurocutaneous Syndrome Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...
March 2024
49 pages
Heparin Market Report by Product (Unfractionated Heparin, Low Molecular Weight Heparin (LMWH), Ultra-Low Molecular Weight Heparin (ULMWH)), Source (Bovine, Porcine), Mode of Administration (Oral, Parenteral), Application (Atrial Fibrillation & Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others), End-User (Hospitals, Clinics, Homecare Settings, Ambulatory Surgical Centers, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Stores, and Others), and Region 2024-2032
US$ 2,999.00
The global heparin market size reached US$ 7.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 8.9 Billion by 2032, exhibiting a growth rate (CAGR) of 2.2% during 2024-20...
March 2024
148 pages
Intravenous Solutions Market Report by Type (Partial Parenteral Nutrition, Total Parenteral Nutrition), Nutrients (Carbohydrates, Salts and Electrolytes, Minerals, Vitamins, Amino Acids), and Region 2024-2032
US$ 2,999.00
The global intravenous solutions market size reached US$ 14.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 23.2 Billion by 2032, exhibiting a growth rate (CAGR) of 4.9...
March 2024
141 pages
Epinephrine Market By Product Type (Auto-Injector, Prefilled Syringe, Others), By Application (Anaphylaxis, Cardiac Arrest, Others), By Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2022 - 2032
US$ 3,570.00
The epinephrine market was valued at $2.6 billion in 2022 and is projected to reach $4.4 billion by 2032, registering a CAGR of 5.6% from 2023 to 2032. Epinephrine, also known as adrenaline, is a horm...
March 2024
266 pages
Chronic fatigue syndrome Market - 2024-2031
US$ 3,400.00
The Chronic fatigue syndrome Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver...
February 2024
50 pages
Graft Versus Host Disease Treatment Market - 2024-2031
US$ 3,400.00
The Graft Versus Host Disease Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight...
February 2024
61 pages
Overt Hepatic Encephalopathy Treatment Market - 2024-2031
US$ 3,400.00
The Overt Hepatic Encephalopathy Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresi...
February 2024
64 pages
Choroidal Neovascularization Market - 2024-2031
US$ 3,400.00
The Choroidal Neovascularization Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to del...
February 2024
54 pages
Esomeprazole Market - 2024-2031
US$ 3,400.00
The Esomeprazole Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparallele...
February 2024
38 pages
